OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹102 Cr | ₹70 Cr | ₹54 Cr | ₹54 Cr | ₹31 Cr |
What is the latest Total Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹102 Cr |
| Mar2025 | ₹70 Cr |
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹54 Cr |
| Mar2022 | ₹31 Cr |
How is Total Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹102 Cr | 46.48 | |
| Mar2025 | ₹70 Cr | 28.21 | |
| Mar2024 | ₹54 Cr | 0.36 | |
| Mar2023 | ₹54 Cr | 74.06 | |
| Mar2022 | ₹31 Cr | - | |
Compare Total Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹173.9 Cr | -3.1% | -10.9% | -21.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -3.1% |
-10.9% |
-21.2% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses